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Abstract  
Introduction: Treatment of myocardial infarction (MI) has been successfully developed, especially after 
introducing primary percutaneous coronary intervention (PPCI) as it nowadays is the recommended 
treatment for ST-segment elevation myocardial infarction (STEMI). 
Objective: This study aimed to evaluate the in-hospital mortality of STEMI patients treated with PPCI 
according to gender and other likely risk factors.  
Methods: This cross-sectional study presents a part of the results of a single-center registry in Imam Ali 
cardiovascular center affiliated to Kermanshah University of medical science (KUMS). From June 2016 to 
December 2017, 731 consecutive patients undergoing PPCI registered. Data were collected using a case report 
form developed by European Observational Registry Program (EORP). The relationship between in-hospital 
mortality and predicting variables was assessed using the Chi-square test, t-test, and univariate and 
multivariate logistic regression models (Forward LR). 
Results: Totally, 155 patients (approximately 21%) were female. The mean age of women and men was 65.2 
and 57.5, respectively (p=0.001). There were differences between women and men in hypertension (58.1% 
vs. 30.4%, respectively, p=0.001), diabetes mellitus (26.5% vs. 14.9%; p=0.001), hypercholesterolemia (37.4% 
vs. 18.6%; p=0.001), and history of prior congestive heart failure (5.2% vs. 2.0%; p=0.016). Although more 
men were current smokers (58.7% (men) vs. 15.5% (women); p=0.001). Women had a significantly greater 
incidence of multi-vessel disease, thrombolysis in myocardial infarction (TIMI) flow grade of 0/1 before PPCI, 
and longer symptom-to-balloon time. In-hospital mortality was higher in women than in men (5.2% vs. 1.9%; 
p=0.024). Multivariate analysis identified age ≥ 60 years, Killip class≥ II, and post-procedural TIMI flow grade 
< 3, but not female sex, as independent predictors of in-hospital mortality. 
Conclusion: In-hospital mortality after PPCI in women was higher than men, though this difference was likely 
due to the severe clinical profile in women. Also, female gender was not identified as an independent predictor 
of death. 
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INTRODUCTION
Acute coronary syndromes (ACS), including 
myocardial infarction (MI), is well recognized as 
one of the most common causes of mortality 
worldwide. Also, it needs well-established 
protocols and management of human and 
technological capacities, which require ever-
increasing financial resources (1). Various factors, 
including therapeutic strategies, cardiovascular 
risk factors, and demographic characteristics may 
affect MI outcomes. Previous studies have reported 
differences in outcome between women and men 
after MI; however, the results have remained 
conflicting (2). Furthermore, it has been 
consistently reported that women are at increased 
risk of traditional risk factors for MI, such as 
diabetes mellitus (DM) (3). Several studies have 
demonstrated that women with ST-segment 
elevation myocardial infarction (STEMI) experience 
worse clinical outcomes and higher mortality than 
men (4, 5), whereas some researchers have 
identified no difference in the mortality rate 
between men and women after the adjustment for 
differences in baseline characteristics (6, 7).  
Treatment for MI has been successfully developed, 
especially after introducing primary percutaneous 
coronary intervention (PPCI) as it nowadays is the 
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recommended treatment for STEMI in high-income 
countries (8). However, STEMI care provided for 
women lags behind that offered to men. Generally, 
women are less likely to be undertreated with 
lifesaving therapy compared to men (9). Besides, 
compared with men, women are less likely to be 
treated by PPCI, although women can derive 
significant benefits from PPCI (10). Moreover, the 
treatment delay in women with STEMI has been 
well established. Despite improving the door-to-
balloon (DTB) time, the gender-related disparity in 
D2BT performance has not been ceased yet (11). 
Thus, 4-steps STEMI protocol was designed to 
improve STEMI care and outcomes for both men 
and women, as well as enhancing women's 
contribution towards the reduction of gender-
related disparity (12). 
Despite that studies have shown improvement in 
outcomes of patients treated with PPCI, gender-
related differences in mortality rate after this 
treatment have not been sufficiently addressed yet, 
especially in low- and middle-income countries 
(13, 14). Furthermore, mortality has been reported 
to be higher in women treated with PPCI compared 
with men, though some other studies showed no 
difference in the mortality rate between men and 
women after adjustment for possible confounders 
(e.g., age) (15-18). Therefore, the disparity in 
mortality rate between women and men treated 
with PPCI has not been well recognized (14). 
Moreover, it is not evident whether female gender 
or differences in baseline characteristics can 
account for the potential differences in the 
mortality rate (14).  
The PPCI network should be founded on the needs 
of both current and future populations to make an 
optimal balance. As population demographics are 
shifting, gender-specific risks of mortality after 
PPCI become prerequisites for future planning. 
Therefore, this study aims to evaluate the baseline 
and clinical characteristics and the potential 
disparity in mortality, as well as other likely 
associated factors, between women and men with 
STEMI treated with PPCI.  
Methods 
Study setting  
This cross-sectional study was included in a 
registry of consecutive patients with STEMI in 
Imam Ali Cardiovascular Center, Kermanshah 
University of Medical Sciences (KUMS), which is the 
leading cardiovascular center in western Iran 
covering about two million population (mostly 
Kurdish with the Caucasian race). All data were 
adjudicated using the standards of the European 
Observational Research Program (EORP). The 
Research Ethics Committee at the Deputy of 
Research of KUMS had approved the study protocol 
in June 2017 (Ethics registration cod= 
KUMS.REC.1395.252). Further, the participants 
had been given the participant information 
statement and had signed the written consent 
form. Also, the personal information of individuals 
was kept confidential. 
Study population 
All patients who underwent PPCI for STEMI from 
July 1, 2016, to December 1, 2017, were assessed. 
The inclusion criteria considered in the study were 
as follows: age ≥ 18-year-old; clinical symptoms of 
STEMI including chest pain or equivalent 
symptoms of more than 20 minutes during the last 
24 hours before admission and 
electrocardiographic (ECG) changes consistent 
with new or presumed new ST-segment elevations 
or left bundle branch block (LBBB) according to 
third universal definition of MI defined by the 
European Society of Cardiology/ACCF/AHA/World 
Heart Federation Task Force for the Universal 
Definition of Myocardial Infarction (19). Quality 
control, in particular validation of diagnosis, was 
supervised by a physician. The patients with the 
following conditions were excluded from the study: 
patients admitted in the hospital for another 
reason and then developed STEMI; and/or patients 
hospitalized in another medical center more than 
24 hours; and/or patients who did not sign the 
consent form to participate in the study. 
Data collection 
Data were collected using case report forms 
(developed by the EORP) by a nurse and research 
assistant - well trained regarding protocols for 
patient entry and data gathering - working in the 
Kermanshah Cardiovascular Research Center 
(KCRC). All case report forms were checked and 
approved by a physician responsible for quality 
control, followed by being forwarded online to the 
EORP website. Patients' national identification 
numbers were used to avoid duplicate admissions 
to this registry. Variables included in the analyses 
were as follows: demographic information (e.g., 
age); clinical histories (e.g., prior MI); 
cardiovascular risk factors (e.g., smoking); 
admission process (e.g., DBT time); biochemical 
findings (e.g., serum cholesterol), ECG results (e.g., 
heart rate); treatment strategies (e.g., PPCI); 
clinical outcomes (e.g., vital status).  
Statistical methods  
Quantitative Variables (e.g., age) were described 
using mean ± standard deviation (SD) and 
qualitative/categorical variables (e.g., smoking) 
ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2020;4(3):e76 Siabani et al 
   
 
3 Copyright © 2020 Tehran University of Medical Sciences  
This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
were expressed as frequencies and percentages. 
Differences between groups were assessed using 
the chi-square test (or Fisher exact tests) for 
categorical variables, and independent t-tests were 
performed for continuous and normally 
distributed variables. The univariate regression 
analysis was performed followed by multivariate 
regression analysis to identify independent 
predictors of in-hospital mortality. It is worth 
noting that the univariate analysis was conducted 
for all independent variables, whereby three 
univariate significant predictors were then 
selected for multiple regression. Odds ratios (ORs) 
and 95% confidence intervals (CIs) were calculated 
for variables. In the univariate model, age ≥ 60 
years old, body mass index (BMI) ≥ 25, 
hypertension (HTN), DM, current smoking, 
hypercholesterolemia, congestive heart failure 
(CHF), Killip class (at first presentation) ≥ II, prior 
PCI, radial access, symptom-to-balloon (STB) time 
> 360 minutes and door-to-balloon (DTB) time > 90 
minutes (20), thrombolysis in myocardial 
infarction (TIMI) grade < 3 after PCI, TIMI grade 
pre 0-1, multi-vessel (culprit vessel ≥ 2), and drug-
eluting stent (DES)  were used as independent 
variables, whereas in-hospital mortality was 
assumed as the dependent variable. All of the 
analyses were considered significant at P<0.05 and 
performed using the statistical package for social 
science (SPSS) software, version 22 (IBM Corp., 
Armonk, NY USA).  
RESULTS 
Baseline characteristics  
A total of 1209 patients with STEMI (957 (79.2%) 
men and 252 (20.8%) women) met the inclusion 
Table 1: Baseline characteristics stratified by sex 
Variable   Men (n=576) Women (n=155) P-value 
Age (y)* 57.57±12.16 65.18±9.94 0.001 
Body mass index 26.24±3.77 27.00±4.13 0.083 
Current smoker 338 (58.7) 24 (15.5) 0.001 
Diabetes mellitus 86 (14.9) 41 (26.5) 0.001 
Hypercholesterolemia 107 (18.6) 58 (37.4) 0.001 
Hypertension 175 (30.4) 90 (58.1) 0.001 
Prior congestive heart failure 11 (2.0) 8 (5.2) 0.016 
Killip class ≥ П 46 (8.0) 10 (6.5) 0.504 
Prior percutaneous coronary intervention 37 (6.5) 9 (5.8) 0.779 
* Continuous variables expressed as mean ± SD, otherwise n (%). 
 
Table 2: Procedural and angiographic characteristics according to sex 
Variable   Men (n=576) Women (n=155) P-value 
Door-to-balloon time (min)* 110.91±104.71 133.07±131.79 0.303 
Symptom-to-balloon time (min) 316.63±273.37 394.30±320.77 0.001 
Vascular access site   
0.061 Femoral  312 (54.2) 95 (61.3) 
Radial  264 (45.8) 60 (38.7) 
Number of culprit vessels   
0.048 
1-Vessel 179 (31.1) 40 (25.8) 
2-Vessel 213 (37.0) 48 (31.0) 
3-Vessel 184 (31.9) 66 (43.2) 
Culprit vessel   
0.309 
Left anterior descending 317 (55.0) 75 (48.4) 
Left main stem 11 (2.0) 2 (1.3) 
Circumflex 73 (12.7) 20 (12.9) 
Right coronary artery 184 (32.0) 59 (38.1) 
Lesion treated at PCI 24 (4.2) 11 (7.1) 0.126 
Thrombolytic therapy 258 (44.8) 52 (33.5) 0.013 
Stent use   
0.638 Bare metal stents 14 (2.4) 5 (3.2) 
Drug- eluting stents 499 (97.6) 139 (96.8) 
Pre-procedural TIMI flow grade   
0.021 
0/1 533 (92.5) 136 7.7) 
2 40 (6.9) 16  (10.3) 
3 2 (0.6) 3 (2.0) 
Post-procedural TIMI flow grade   
0.301 
0/1 7 (1.2) 1 (0.6) 
2 23(4.0) 11`(7.1) 
3 545 (94.8) 143 (92.3) 
* Continuous variables expressed as mean ± SD, otherwise n (%). 
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criteria for the present study. Among them, 731 
(60.5%) patients (576 (78.8%) men and 155 
(21.2%) women) were treated with PPCI. Also, 
there was no difference in treatment with PPCI 
between the women (155/252, 61.2%) and men 
(576/957, 60.2%). Women were older than men on 
average, i.e., the mean (±SD) age for women was 
65.79±11.34 years, and it was 59.04±12.39 years 
for the men (p=0.001). The prevalence of some 
comorbidities such as DM, hypercholesterolemia, 
HTN, and prior CHF was significantly higher in 
women, though substantially fewer women were 
current smokers. Moreover, the Killip 
classifications (p=0.504) and prior PCI (p=0.779) 
showed negligible differences between men and 
women (Table 1).  
Procedural and angiographic characteristics  
The median STB time (or treatment delay) was 
dramatically longer for women than men 
(p=0.001). Women were more likely to have PCI via 
femoral rather than the radial approach. Also, 
women had a higher incidence of multi-vessel 
disease with 2 or 3 culprit vessels compared with 
men (p=0.048). The left anterior descending (LAD) 
and right coronary artery (RCA) were the most 
often culprit vessel in both groups, respectively. 
The performance of thrombolytic therapy was 
more prevalent and significant in men than women 
(45% vs. 33%; p=0.013). Moreover, TIMI flow 
grade 0/1 before PPCI was much more frequent in 
men (p=0.021), whereas it was similar between 
men and women after PPCI (p= 0.301) (Table 2). 
In-hospital and discharge medication 
Similar treatment patterns existed for in-hospital 
medication use, thought, at discharge, prescription 
of aspirin (p=0.041) and clopidogrel (p=0.026) was 
significantly lower in women (Table 3). 
In-hospital mortality 
In-hospital mortality of the total sample was 2.6%. 
Higher in-hospital mortality was observed among 
women than men (5.2% vs. 1.9%; p=0.024). The 
analytical results of logistic regression (Forward 
LR) identified age ≥ 60 years (OR 4.81, 95% CI 1.20-
19.23; p=0.031), Killip class ≥ П (OR 12.39, 95%, CI 
3.72-40.89; p<0.001), and post-procedural TIMI 
flow grade < 3 (OR 11.87, 95% CI 3.36-41.88; 
Table 3: In-hospital and discharge medication according to sex 
Variable Men (n=576) Women (n=155) P-value 
In-hospital therapy    
Aspirin 576 (100.0) 154 (99.4) 0.205 
Clopidogrel  573 (99.5) 155(100.0) 0.305 
Unfractionated heparin 554 (96.2) 152 (98.0) 0.306 
Low molecular weight heparin 175 (30.4) 46 (29.7) 0.802 
Warfarin  4 (0.7) 1 (0.7) 0.926 
Discharge therapy    
Aspirin 559 (97.0) 145 (93.5) 0.041 
Clopidogrel 561(97.4) 145(93.5) 0.026 
Warfarin 11 (1.9) 1(0.7) 0.203 
β-Blocker 444 (77.1) 119 (76.8) 0.935 
Angiotensin Converting Enzyme inhibitors  331(57.5) 78 (50.4) 0.061 
Statin  554(96.2) 145(93.5) 0.125 
 
Table 4: Univariable and multivariate (Forward LR) analysis of in-hospital mortality, all patients 
Risk factor 
Univariable Multivariable 
OR (95% CI) P-value OR (95% CI) P-value 
Female gender  1.78 (0.35-8.88) 0.475   
Age≥ 60 y 2.98 (1.06-8.36) 0.038 4.81 (1.20-19.23) 0.031 
Body mass index ≥ 25 1.03 (0.40-2.66) 0.943   
Current smoker 0.46 (0.17-1.23) 0.121   
Diabetes mellitus 1.24 (0.41-3.81) 0.702   
Hypercholesterolemia 0.60 (0.17-2.08) 0.417   
Hypertension 1.26 (0.50-3.16) 0.628   
Previous congestive heart failure 1.71 (0.00-10.86) 1.000   
Killip class ≥ П 7.89 (2.97-20.95) <0.001 12.39 (3.72-40.89) <0.001 
Prior PCI 0.54 (0.00-3.21) 0.571   
Radial access  0.44 (0.16-1.23) 0.119   
Door-to-balloon time ≥ 90 1.13 (0.45-2.84) 0.798   
Symptom-to-balloon Time ≥ 360 1.28 (0.48-3.42) 0.620   
Post-procedural TIMI flow < 3  6.51 (2.22-19.03) 0.001 11.87 (3.36-41.88) <0.001 
Pre-procedural TIMI flow 0-1 2.51 (0.42-+Inf) 0.3729   
Multi-vessel  1.63 (0.54-4.98) 0.388   
Drug- eluting stents 0.60 (0.17-2.11) 0.426   
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p<0.001) as factors independently associated with 
in-hospital mortality (Table 4).  
DISCUSSION 
This study revealed that women have presented 
STEMI in older ages with a higher prevalence of 
traditional risk factors. Women have suffered 
STEMI as frequently as men treated with PPCI, 
although the post-PCI mortality rate was higher in 
women. After adjustment for baseline 
characteristics, it was observed that female gender 
could not independently predict mortality in 
patients treated with PCI for STEMI.  
Prior studies have shown a mean age range of 58.8–
60.9 years for men and 65.5-67.5 years for women 
(2, 21, 22), which are consistent with the findings 
of the present study (57.57and 65.18 for men and 
women, respectively). The later development of 
cardiovascular disease, i.e., STEMI, in women is 
attributed to differences in endogenous sex 
hormones, especially the protective effect of 
estrogen until menopause starts (23). Mean age of 
women with STEMI was almost eight years older 
than men. Also, the incidence of some 
comorbidities such as hypercholesterolemia, DM, 
HTN, and prior CHF was markedly higher in 
women. Other studies have also reported that 
women with STEMI are older, have HTN and DM, 
and have higher comorbidities more often (24, 25). 
Since the prevalence of DM and HTN increases by 
aging and the vardiovascular disease (CVD) starts 
in women at an older age compared with men, 
women are more susceptible to suffering DM and 
HTN at presentation.  
Moreover, the obtained results demonstrated some 
key gender differences in procedural and 
angiographic characteristics. As shown by 
Wijnbergen et al. (26), Matthijs et al. (27), and 
Barbosa et al. (2), STB time (or treatment delay) 
was considerably longer in women. Furthermore, 
lack of awareness about cardiovascular risk factors 
and failure to recognize symptoms might be a 
potential explanation for the longer STB time in 
women and, in turn, longer time between onsets of 
symptoms until arrival in the cat lab. Besides, STB 
time was not an independent risk factor for 
mortality in multivariate analysis, which was most 
likely due to the difference between the patient's 
median STB time and standard STB time by 
approximately 30 min that might not be long 
enough to affect mortality significantly.  
Moreover, consistent with the study conducted by 
Wei et al. (28), the men were more likely to have 
pre-procedural TIMI flow grade 0/1. Also, Zhang et 
al. (29) observed that female patients had a higher 
incidence of Multivessel disease with 2 or 3 culprit 
vessels compared to men, agreeing well with the 
results of the present study. However, to the 
contrary, Akhter et al. (30) reported a higher 
prevalence of single-vessel disease in women. 
Previous studies have shown that, based on the 
American College of Cardiology and the American 
Heart Association, medical therapies are given less 
commonly to women at the time of admission and 
discharge (31, 32). In the present study, discharge-
recommended medical therapies were given less 
often to women. The most significant differences 
were observed in the administration of antiplatelet 
therapies such as aspirin and Clopidogrel at the 
time of discharge, which may be due to the higher 
incidence of adverse bleeding events and vascular 
complications after PPCI among females (24, 33). 
In the past, women had higher in-hospital mortality 
after PPCI (2, 25). Nowadays, fortunately, there has 
been a trend toward improvement in post-PPCI 
mortality rates in women (34). However, in the 
present study, higher rates of in-hospital mortality 
have been reported in women; conversely, Zhang et 
al. (35) stated that women with STEMI treated with 
sirolimus-eluting-stent based primary PCI had the 
same in-hospital mortality as their male 
counterparts. The higher in-hospital mortality 
observed in women may be attributed to several 
factors. Firstly, in our society, older age and 
baseline risk factors in women have increased their 
in-hospital mortality rates, and if these factors are 
adjusted, the risk of in-hospital mortality will be 
equalized for both genders, which is consistent 
with the results of earlier studies (36, 37). 
Secondly, a higher incidence of PCI failure was 
reported in women, despite similar angiographic 
characteristics. Besides, as previously reported, the 
incidence of major bleedings was higher in women 
(24).  
Consistent with a trend toward improved in-
hospital mortality rates after PPCI in women (34), 
a significant gender difference in adjusted 
mortality rates was not observed in this study as 
well. In other words, the female gender was not an 
independent predictor of in-hospital mortality in 
the multivariate analysis, which agrees properly 
with the findings of previous studies. Birkemeyer 
et al. (24) reported that the female gender failed to 
be predictive as an independent variable for in-
hospital mortality after PPCI. Kanic et al. (38) 
showed that the female gender was not an 
independent prognostic factor in in-hospital 
mortality in patients with STEMI treated with PCI. 
De Luca et al. (39) investigated 1548 patients with 
STEMI and illustrated that the female gender was 
ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2020;4(3):e76 Siabani et al 
   
 
6 Copyright © 2020 Tehran University of Medical Sciences  
This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
not an independent risk factor in in-hospital 
mortality. 
However, many studies reported converse results. 
For instance, Matthijs et al. (27) concluded that the 
female gender independently predicted the 
mortality of patients with STEMI treated with PCI. 
Also, Pu et al. (40) demonstrated that female 
gender was an independent predictor of mortality 
in patients with STEMI. Likewise, Benamer (25) 
conducted a study identical to the present work, 
showing that female gender was an independent 
risk factor for in-hospital mortality after PPCI for 
STEMI.  
Furthermore, Killip class≥ П at admission, age ≥ 60 
years, and post-procedural TIMI flow<3 were 
identified as independent factors associated with 
the in-hospital mortality, indicating that elderly 
patients and those with high clinical severity have 
been at higher risk of death. Similar results were 
obtained for these variables in other researches. 
Barbosa et al. (2) showed that Killip class≥ П at 
admission and age ≥ 70 years were independent 
predictors of in-hospital mortality after PCI. Also, 
in another study conducted in the Netherlands 
(2013), post-procedural TIMI flow < 3 was 
recognized as an important predictor of in-hospital 
mortality after PCI for STEMI (27).   
Limitations 
The most important limitation of the current study, 
as an observational registry, was non-randomized 
nature and confounding factors, which cannot be 
controlled. However, the dataset of this work 
included all basic variables influencing mortality, 
which would support the validity of our findings. 
Furthermore, since only patients with STEMI 
treated with PCI were evaluated, this analysis 
cannot be generalized to different treatment 
patterns among patients who were not treated 
with PCI. Also, since the data were derived from a 
single-center, the results may not express the 
whole community. 
CONCLUSIONS 
In conclusion, women with STEMI have shown 
higher mortality rates after primary PCI compared 
with men, fairly due to older age and a higher 
prevalence of traditional risk factors at 
presentation. Indeed, post-PCI mortality was not 
independently associated with female gender after 
adjustment for baseline characteristics. Despite 
that the women with STEMI were at higher risk, the 
discharge-recommended medical therapies were 
used less frequently in women, which entails more 
investigation. Moreover, quality efforts geared 
toward decreasing mortality in general, with a 
specific focus on women, are required to help 
decrease post PCI mortality and reduce gender-
related disparity in this adverse event. 
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